Open access peer-reviewed chapter

Prologue: Deep Insights of Chemical Structures by Chemoinformatics Tools, Let’s Think Forward!

By Amalia Stefaniu

Reviewed: February 21st 2020Published: July 15th 2020

DOI: 10.5772/intechopen.91858

Downloaded: 316

1. Introduction - Multidisciplinary context

The constant need of chemical scientists to understand complex phenomena and process and to achieve a rational structural design by controlling the synthesis to obtain compounds with improved properties or materials with enhanced quality, together with advances in information technology, has led to development of a new branch of chemistry—chemoinformatics—with strong implications in life sciences such as molecular biology or biochemistry, with major interest in medicine, pharmaceutical and food science industries.

Mainly, these interdisciplinary efforts are focused on the medical and pharmaceutical area, aiming to improve the quality and standard of life, and have applications in drug design and development of new therapeutic strategies. Chemoinformatics, as new discipline, covers a broad spectrum of aspects including all applications of information technology to chemistry involving: constructing and archiving big compound libraries (small molecules and proteins) containing structural properties and molecular descriptors, spectra, X-ray crystallography data and so on; information processing; large-scale chemical data mining; computational tools for structure and interactions visualisation, computational models for predicting interactions, to calculate properties and bioactivity, molecular docking and dynamic simulations methodologies, virtual screening, pharmacophore modelling, fragments similarity analysis, estimation of ADME (absorption, distribution, metabolism and excretion) characteristics, toxicity alerting, etc. [1, 2, 3, 4]. The integration of chemical information and its transformation involves mathematical models and statistical data analysis.

Due to web servers and open data initiatives, large amount of chemical data from screening libraries are now available [5] and facilitate the drug discovery process. There are numerous chemoinformatics databases which contain various experimental and/or predicted properties of small molecules (ligands), peptides, proteins and data about their interactions (drug-drug interactions, ligand-protein interactions, protein-protein interactions, RNA-ligand interactions), chemical toxicity, bioactivity, adverse drug reactions, drug pathways, toxicogenomics, secondary metabolites, pharmacokinetics, etc. The existing data could help to build new structures and new models and to make new in silico predictions about physico-chemical properties and behaviour.

To raise awareness of the outstanding importance and impact of chemoinformatics research, exemplified below are some of its applications in life sciences, preponderant in medicinal chemistry.


2. Applications of chemoinformatics in medicinal chemistry

Novel druggable protein targets are a subject of research in order to develop new therapeutic strategies against various diseases (scleroderma, Alzheimer’s disease, infections, etc.). Investigations include methods such as quantitative structure-activity relationships (QSAR), similarity search, pharmacophore modelling, molecular docking and dynamic simulations and toxicity assessment.

2.1 Anticancer therapy design

To fight against malignancies, new screening methods aim to identify and develop novel chemical antiproliferative agents, with promising results. As example, biomolecular modelling techniques are used to identify potential kinase inhibitor targets. The mitogen-activated protein kinase (MAPK) plays a key role in tumorigenesis; that is why it is considered a priority druggable target candidate for anticancer therapy. The interactions of cancer-related MAPK kinases and potential inhibitors are investigated by in silico tools. Molecular docking calculations are employed to predict the inhibitor-bound active sites and the binding modes for actual and potential anticancer drugs [6].

2.2 Parkinson’s disease

Researchers’ efforts to improve medication for Parkinson’s disease benefit from chemoinformatics and molecular docking tools to identify new potential neuroprotective compounds able to effectively treat the disease, by inhibition of oligomerization process of α-synuclein protein. By computational techniques, the protein in its dimer and oligomer forms can be studied, and multiple molecules are subject of computational simulations in order to identify potential inhibitors of α-synuclein aggregation [7].

2.3 Alzheimer’s disease

Chemoinformatics approaches including molecular docking, dynamic simulations, lead optimization and quantum chemical characterisation are used to achieve the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, responsible for cholinergic dysfunctions associated with the cognitive and behavioural abnormalities in dementing illness, in order to design and develop new therapeutic agents against this disease [8, 9, 10, 11]. Other approaches focus on the amyloid-beta aggregation process, trying to stop the formation of neurotoxic species, and the design of new inhibitors, the study being also facilitated by computational techniques such as QSAR modelling and assessment of inhibition efficiency by predicting stability and binding modes of potential inhibitors through combined computational techniques including structure-activity relationships analysis, docking and molecular dynamic simulations [12, 13, 14, 15].

2.4 Antimicrobial agents

Researchers focus their studies to block the activity of DNA gyrase and topoisomerase IV, which are essential bacterial enzymes involved in replication and recombination processes. The design of novel antibacterial agents that act against these enzymes can be realised by molecular docking techniques and bioactivity evaluation. That is the case of quinolones, which act equally against DNA gyrase and topoisomerase IV [16, 17, 18, 19].

Pharmacokinetics/ADMET propertiessuch as absorption, distribution, metabolism, excretion and toxicity of designed structures are assessed through computational approaches too, aiming to predict the therapeutic potential of the lead compound. Biochemical properties and drug-likeness according Lipinski’s rule of five (RO5) [20] and the molecular flexibility, as key descriptors to describe the oral bioavailability of drugs, are also predicted using computational tools. Thus, computer-aided drug design, coupled with in silico ADMET studies, helps to select the drug candidate molecules with possible better efficacy and less side effects (poor hepatotoxic effects).

3. Application in identification and quantification of substances of abuse

Recent researches report the application of chemometric tools in correlation with spectrometric techniques (near-infrared spectroscopy) for onsite analysis of cannabinoids or amphetamine compounds (with portable and handheld NIR devices). The chemometric tools allow the user to compare collection of spectra, to develop prediction models and to achieve a real-time detection of sample contamination. Such method could become an alternative way of detection of illicit drugs, determined in oral fluids, being non-invasive, rapid and accurate test, completely automated [21, 22].

4. Applications in food chemistry

Food chemical data sets can be manipulated and analysed also by computational resources similar with those for drugs and nutraceuticals. The interest in this area is growing because of the food-related industrial challenges. Thus, an emerging field of research has arisen: foodinformatics [23]. In silico quantitative approaches are used to assess genotoxicity and carcinogenicity of food additives (flavours, colourants, contaminants, etc.) or cosmetic ingredients [24, 25, 26], in the attempts of safety evaluation for the human health. All these computational approaches must be verified by in vitro methods.

This section is a collection of advanced studies focusing on topics of interest in the context of chemoinformatics applications in drug discovery and design of new molecules.

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Amalia Stefaniu (July 15th 2020). Prologue: Deep Insights of Chemical Structures by Chemoinformatics Tools, Let’s Think Forward!, Cheminformatics and its Applications, Amalia Stefaniu, Azhar Rasul and Ghulam Hussain, IntechOpen, DOI: 10.5772/intechopen.91858. Available from:

chapter statistics

316total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Visible Evolution from Primitive Organisms to Homo sapiens

By Kenji Sorimachi

Related Book

First chapter

Introductory Chapter: Molecular Docking and Molecular Dynamics Techniques to Achieve Rational Drug Design

By Amalia Stefaniu

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us